Syneos Health, Inc. - (SYNH) News
Filter SYNH News Items
SYNH News Results
Date | Symbol | Company | Title | Start | End | Change | POWR Rating | ||
---|---|---|---|---|---|---|---|---|---|
Loading, please wait... |
SYNH News Highlights
- SYNH's 30 day story count now stands at 7.
- Over the past 22 days, the trend for SYNH's stories per day has been choppy and unclear. It has oscillated between 1 and 2.
- The most mentioned tickers in articles about SYNH are AC, CIVI and HAYW.
Latest SYNH News From Around the Web
Below are the latest news stories about SYNEOS HEALTH INC that investors may wish to consider to help them evaluate SYNH as an investment opportunity.
Syneos Health Closes Transaction with Private Investment FirmsTransaction Will Drive Ongoing Transformation and Accelerate Delivery of Tech-Enabled, Fit-for-Purpose Solutions to Biopharma CustomersMORRISVILLE, N.C., Sept. 28, 2023 (GLOBE NEWSWIRE) -- Syneos Health, Inc. (“Syneos Health” or the “Company”), a leading fully integrated biopharmaceutical solutions organization, today announced the completion of its acquisition by a consortium of private investment firm affiliates composed of Elliott Investment Management L.P., Patient Square Capital and Veritas |
Civitas Resources Set to Join S&P MidCap 400; Hayward Holdings to Join S&P SmallCap 600S&P SmallCap 600 constituent Civitas Resources Inc. (NYSE: CIVI) will replace Syneos Health Inc. (NASD: SYNH) in the S&P MidCap 400, and Hayward Holdings Inc. (NYSE: HAYW) will replace Civitas Resources in the S&P SmallCap 600 effective prior to the opening of trading on Friday, September 29. Elliot Investment Management is acquiring Syneos Health in a deal expected to be completed soon pending final conditions. |
Syneos Health Names Terttu Haring President, Clinical Sites & PatientsIndustry Veteran to Play Critical Role in Leading Global Clinical Operations, Cultivating Site Relationships, Empowering Patients and Shaping Innovative Clinical Trial SolutionsMORRISVILLE, N.C., Sept. 26, 2023 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq: SYNH), a leading fully integrated biopharmaceutical solutions organization, has announced the appointment of Terttu Haring, MD, as President, Clinical Sites & Patients. With nearly 30 years of experience, Dr. Haring will lead the global clinical |
Syneos Health (SYNH) Declares Strategic Partnership With OracleSyneos Health (SYNH) announces an expanded collaboration with Oracle to accelerate patient recruitment capabilities. |
Syneos Health and Oracle to Expand Relationship to Accelerate Patient Recruitment & Advance Health EquityMORRISVILLE, N.C., Sept. 12, 2023 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq:SYNH), a leading fully integrated biopharmaceutical solutions organization, today announced a strategic collaboration that will expand its relationship with Oracle. Using the Oracle Cerner Learning Health Network (LHN) and elements of Oracle’s suite of study startup solutions, the companies seek to help reduce the time it takes to recruit patients for clinical studies and increase the diversity of patient populations pa |
Is It Too Late To Consider Buying Syneos Health, Inc. (NASDAQ:SYNH)?While Syneos Health, Inc. ( NASDAQ:SYNH ) might not be the most widely known stock at the moment, it maintained its... |
Syneos Health, Inc. and Star Parent, Inc. Announce Proposed $1.70 Billion Offering of Senior Secured NotesMORRISVILLE, N.C., Sept. 06, 2023 (GLOBE NEWSWIRE) -- Star Parent, Inc. (the “Issuer” or the “Company”) and Syneos Health, Inc. (“Syneos Health”), announced today that, subject to market conditions and other factors, the Issuer intends to offer $1,700,000,000 aggregate principal amount of Senior Secured Notes due 2030 (the “Notes”). The Issuer intends to use the proceeds from the offering together with other financing sources to fund the previously announced acquisition of Syneos Health (the “Ac |
Syneos Health (SYNH) Expands Catalyst Site Program to ChinaSyneos Health (SYNH) announces a collaboration with China's Wuhan Union Hospital, expanding clinical trial capabilities. |
BB Stock Alert: Is Veritas Capital About to Takeover Blackberry?Blackberry (BB) stock jumped a surprise 18% today on rumors that private equity firm Veritas is considering a takeover of the company. |
Syneos Health (SYNH) to Go Private, Reports Q2 PerformanceSyneos Health (SYNH) announces shareholders' approval for the impending merger and releases second-quarter 2023 financial results. |